Aclaris Therapeutics (ACRS) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.01
-0.71
-0.42
-0.12

Details

Expected EPS
-0.136143
Actual EPS
-0.12
Surprise EPS
0.02
Surprise Percent
+11.86%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.12 per share for Q4 2025.

0 Comments

Share your thoughts